ArticleThe oncologist2020

A Phase Ib Study of Single-Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Erkut Borazanci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.